SRPT241206P130000
- 4.80
- +3.65+317.39%
Sarepta Therapeutics Newsroom
H.C. Wainwright Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating, Cuts Target Price to $75
Sarepta Therapeutics: Sell Rating Amid Uncertain Pipeline and Financial Risks
BMO Capital Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $200
Sarepta Therapeutics: Strong Buy Rating Amid Strategic Partnership and Promising Growth Potential
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
Express News | Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Price Target Lowered to $202 From $205 at Needham
A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $215
RBC Capital Remains a Buy on Sarepta Therapeutics (SRPT)
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler
SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies
Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 42.11%: Read This Before Placing a Bet
A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $217
Sarepta Therapeutics (SRPT) Gets a Buy From TD Cowen
Sarepta Therapeutics Receives Buy Rating From Gil Blum: Strategic Partnerships and Financial Stability Highlight Growth Potential
US stocks mining | Nuclear energy stocks collectively rise! CEG's annual increase is nearly 130%; aerospace stocks celebrate together! SpaceX's formidable rival Rocket Lab has surged over 360% this year.
Hundred-billion collaboration agreement finalized! Biotechnology company sarepta therapeutics surged nearly 14% overnight, approaching a three-month high; Medical reimbursement limit increased! Medical diagnostic company exact sciences rose 9% last night.